Global Monkeypox Rapid Test Kit Market Strategic Research Report

Scope of the Report

The global Monkeypox Rapid Test Kit market size is predicted to grow from US$ 970 million in 2025 to US$ 1,656 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

In 2024, global Monkeypox Rapid Test Kit production reached approximately 51.1 million kits, with an average global market price of around US$ 18 per kit. The gross profit margin of major manufacturers ranges between 40% and 60%, and single-line production capacity typically falls between 200,000 and 300,000 kits per year. Monkeypox rapid test kits are in-vitro diagnostic devices designed for the quick detection of the monkeypox virus (MPXV) antigen or antibodies in human samples such as serum, plasma, or swabs. Using immunochromatographic or lateral flow assay technology, these kits can provide results within 10–20 minutes, supporting early diagnosis and outbreak control. They are widely utilized in hospitals, laboratories, border checkpoints, and epidemic response centers.

The monkeypox rapid test kit market is expanding steadily due to recurring outbreaks, growing public awareness, and stronger disease surveillance systems established after the COVID-19 pandemic. Governments and healthcare providers are investing in rapid, field-deployable testing technologies to prevent transmission and improve patient management. Manufacturers are focusing on optimizing sensitivity and specificity while reducing false positives through improved monoclonal antibody design and membrane materials. The increasing use of point-of-care testing (POCT) platforms and digital data integration supports faster epidemiological response. Asia-Pacific and Africa are emerging as key growth regions due to higher prevalence and rising investment in diagnostic infrastructure. However, the market still faces challenges from regulatory variations across regions, limited cold-chain logistics in developing areas, and competition from PCR-based molecular testing. As production becomes more standardized and costs decrease, rapid test kits will remain an essential first-line diagnostic tool for outbreak containment.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monkeypox Rapid Test Kit market?

What factors are driving Monkeypox Rapid Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Monkeypox Rapid Test Kit market opportunities vary by end market size?

How does Monkeypox Rapid Test Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Monkeypox Rapid Test Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Antigen Test
• Antibody Test
• Others

Segment by Application

• Clinical Diagnosis
• Public Health Monitoring
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Monkeypox Rapid Test Kit market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical Diagnosis, Public Health Monitoring, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact